查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1422772

全球免疫诊断市场：按产品类型、按应用、按最终用户、按地区、机会、预测，2017-2031

Immunodiagnostics Market Assessment, By Type, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 238 Pages | 商品交期: 3-5个工作天内

价格

2023年全球免疫诊断市场规模为212.1亿美元，预计2031年将达458亿美元，复合年增长率预计为10.1%。 推动全球免疫诊断市场的因素包括传染病的快速增加、诊断技术的进步、对个人化医疗的需求不断增长以及对疾病早期检测的意识不断增强。 此外，人口老化、医疗基础设施改善以及自体免疫疾病发病率上升等因素也推动了免疫诊断市场的成长。

由于各种相互关联的因素，全球免疫诊断市场正在不断成长。 一个重要的驱动因素是传染病的全球流行。 这种快速成长需要高效的诊断工具，并正在推动先进免疫诊断技术的开发和实施。 这些技术进步促进了更准确、更快速的疾病识别，并在全球免疫诊断市场的成长中发挥关键作用。 另一个因素是对个人化医疗的需求不断增长。 随着人们认识到免疫反应存在个体差异，对客製化诊断方法的需求正在迅速增加。 免疫诊断能够评估免疫系统功能并识别特定的生物标记物，完全满足个人化医疗的需求。

此外，提高对疾病早期检测的认识已成为全球医疗保健系统的一个重要焦点。 免疫诊断能够及早发现各种疾病，以便及时介入并改善患者预后。 此外，人口老化等人口变化正在推动对免疫诊断解决方案的需求。 随着年龄的增长，我们对各种疾病的易感性增加，对精确诊断工具的需求也随之增加。 此外，自体免疫疾病的增加进一步推动了全球免疫诊断市场的成长，因为准确的诊断和监测对于管理这些复杂疾病至关重要。

对个人化医疗日益增长的需求正在刺激全球免疫诊断市场的成长。 透过根据具体的个体特征量身定制治疗，可以最大限度地提高疗效，同时最大限度地减少负面影响。 免疫诊断在评估人体对疾病的免疫反应方面发挥重要作用，有助于准确的治疗选择和诊断。 需求激增源自于多种因素。 基因组学和蛋白□□质组学等技术的进步使人们能够更深入地了解个别患者的特征并促进有针对性的治疗。 此外，慢性病和传染病的流行凸显了对准确、快速诊断的需求，这与免疫诊断的能力完全一致。

此外，随着世界人口老化，需要更量身订做的医疗保健解决方案，进一步推动市场扩张。 持续的趋势预计将推动免疫诊断领域的成长。 创新和投资将催生更复杂、更准确和个人化的诊断工具，从而彻底改变医疗保健服务系统。

本报告考察了全球免疫诊断市场，并提供了市场概述，包括按产品类型、应用、最终用户、地区和进入市场的公司概况划分的趋势。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章全球免疫诊断市场展望，2017-2031

  • 市场规模与预测
  • 依类型
  • 按产品
  • 依用途
  • 按最终用户
  • 按地区
  • 各公司的市占率 (%)，2023 年

第 5 章 2017-2031 年全球免疫诊断市场前景（按地区）

  • 北美
  • 欧洲
  • 南美洲
  • 亚太地区
  • 中东/非洲

第 6 章市场地图，2023 年

第七章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

第 9 章监理架构与创新

第十章主要参会企业状况

第11章价格分析

第 12 章案例研究

第十三章主要公司展望

  • Bio-Rad Laboratories, Inc
  • Johnson & Johnson Services, Inc.
  • Immunodiagnostics Systems Holdings Plc
  • F. Hoffman-La Roche Ltd.
  • Arkray, Inc.
  • Siemens AG
  • bioMerieux SA
  • Danaher Corporation
  • Sysmex Corporation
  • Abbott Laboratories Inc.
  • Diasorin S.P.A.
  • Thermo Fisher Scientific, Inc.

第 14 章策略建议

第十五章查询及免责声明

Product Code: MX10970

Global immunodiagnostics market size was valued at USD 21.21 billion in 2023, expected to reach USD 45.8 billion in 2031, with a CAGR of 10.1% for the forecast period between 2024 and 2031F. Factors propelling the global immunodiagnostics market encompass the upsurge in infectious diseases, advancements in diagnostic technologies, amplified demand for personalized medicine, and heightened awareness regarding early disease detection. Moreover, the growth of the global immunodiagnostics market is fueled by factors such as the aging population, improvement in healthcare infrastructure, and increasing autoimmune conditions.

The global immunodiagnostics market is witnessing an upward trajectory due to various interconnected factors. One of the significant drivers is the increasing prevalence of infectious diseases worldwide. The surge necessitates efficient diagnostic tools, leading to the development and adoption of advanced immunodiagnostic techniques. These technological advancements play a pivotal role in the growth of the global immunodiagnostics market, facilitating more accurate and rapid disease identification. Another contributing factor is the amplified demand for personalized medicine. The recognition of individual variations in immune responses has led to a burgeoning need for tailored diagnostic approaches. Immunodiagnostics, with its ability to assess immune system functions and identify specific biomarkers, aligns perfectly with the requirements of personalized medicine.

Furthermore, heightened awareness regarding early disease detection has become a key focus across healthcare systems globally. Immunodiagnostics offers the advantage of early identification of various conditions, enabling timely intervention and improved patient outcomes. Moreover, demographic shifts, such as aging populations, drive the demand for immunodiagnostic solutions. As age increases, the susceptibility to various diseases rises, elevating the requirement for precise diagnostic tools. Additionally, the escalation of autoimmune conditions further fuels the growth of global immunodiagnostics market, as accurate diagnosis and monitoring become crucial in managing these complex diseases.

Amplified Demand for Personalized Medicine

The increased desire for personalized medicine has stimulated the growth of global immunodiagnostics market. Tailoring treatments to specific individual traits maximize effectiveness while reducing negative impacts. Immunodiagnostics play a crucial role by evaluating the body's immune response to illnesses, aiding in precise treatment choices and diagnoses. The surge in demand arises from various factors. Technological advancements like genomics and proteomics enable a deeper comprehension of individual patient characteristics, facilitating targeted therapies. Also, the growing prevalence of chronic and infectious diseases highlights the necessity for precise and rapid diagnostics, aligning perfectly with the capabilities of immunodiagnostics.

Moreover, the aging global population demands more tailored healthcare solutions, further propelling the market expansion. Continued trends are anticipated to drive the growth of the immunodiagnostics sector. Innovations and investments will lead to the creation of more refined, precise, and personalized diagnostic tools, significantly transforming healthcare delivery systems.

Advancing Technologies

Technological progress stands as a key driving force for the global immunodiagnostics market. Advances in genomics, proteomics, and data analytics enable a deep comprehension of individual biological intricacies, leading to the creation of extremely accurate diagnostic tools. These breakthroughs enable healthcare providers to thoroughly examine immune responses, facilitating quick and precise disease identification. The fusion of these innovative technologies boosts the effectiveness of immunodiagnostics and propels the development of tailored therapies, transforming healthcare by allowing customized treatments for each patient and elevating the expansion of the global immunodiagnostics market.

For instance, to minimize testing gaps for individuals with pre-diabetes and diabetes, healthcare start-up Orange Biomed introduced their reusable, pocket-sized OBM fast A1c test in the United States in April 2023. The OBM fast A1c technology, billed as the world's first glycated hemoglobin analyzer, was in June during the 83rd Scientific Sessions of the American Diabetes Association, which took place in San Diego, California.

Government Initiatives

Governments globally are actively implementing diverse strategies to strengthen the global immunodiagnostics market. These strategies involve financing research and development, cultivating partnerships between academic and industrial sectors and establishing regulatory structures that promote innovation. Through infrastructure investment, grant provisions, and clinical trials, governments strive to expedite the advancement and acceptance of sophisticated immunodiagnostic technologies. These combined endeavors drive market expansion and aspire to improve public health by encouraging early disease identification, enabling customized therapies, and ultimately advancing healthcare outcomes worldwide. For example, the government of Uttar Pradesh dispatched a delegation to visit three government hospitals in Varanasi in October 2023 to evaluate the situation given the rising number of fever patients in the district. The team evaluated the situation considering the rising number of fever patients in the district and ordered Elisa test kits for chikungunya, leptospirosis, scrub typhus, and other illnesses be made available at the Pandit Deendayal Upadhyay District Hospital in Pandeypur and the SSPG Divisional Hospital in Kabir Chaura.

Rising Demand for ELISA

The rising need for ELISA (Enzyme-Linked Immunosorbent Assay) tests significantly propel the expansion of global immunodiagnostics market. ELISA, known for its high sensitivity and specificity, identifies various diseases by measuring antibodies, proteins, or hormones in samples. Its adaptability in diagnosing infectious diseases, autoimmune conditions, and cancers drives its demand. Factors like increased disease prevalence, technological advancements, improving ELISA's precision, and its cost-effectiveness contribute to its prominence. Healthcare experts rely on ELISA for swift and accurate disease identification, making its increasing utilization a substantial factor in shaping the growth and direction of the global immunodiagnostics market. For example, Neogen Corporation stated in November 2023 that it has launched its third assay in its Veratox VIP range of improved quantitative ELISA solutions, the novel Veratox VIP assay for detecting walnut. The new Veratox VIP for Walnut allergy test keeps the straightforward testing process of the Veratox product range while exhibiting strong performance across sample types.

For Diagnosis of Infectious Diseases

The increase in infectious diseases is driving the growth of the global immunodiagnostics market. The rise in contagious illnesses worldwide requires fast and precise diagnostic tools for quick identification and treatment. Immunodiagnostics holds a crucial position by evaluating the body's immune reactions, assisting in accurate disease detection. Emerging pathogens, antimicrobial resistance, and increased global travel contribute to the surge in infectious diseases. Therefore, the growing demand for efficient diagnostic solutions matches the capabilities of immunodiagnostics, leading to its market expansion to address the urgent requirement for swift and accurate disease identification and treatment worldwide. For example, in September 2023, a group of researchers under the direction of Professor Johnjoe McFadden created a brand-new molecular test known as "Electro-chemical LAMP" (eLAMP), which is quick, inexpensive, sensitive, and able to be used in a hospital lab, GP office, or at home. When coupled to a smartphone, eLAMP allows at-home polymerase chain reaction (PCR) testing with the sensitivity of lab-based PCR assays.

Future Market Scenario

Several compelling factors contribute to a promising future for the global immunodiagnostics market. Ongoing technological advancements continually improve diagnostic tools, refining their precision and adaptability. The progress enables healthcare providers to conduct thorough assessments of immune responses, resulting in more precise disease diagnoses. Furthermore, the increasing demand for personalized medicine propels immunodiagnostics' growth by customizing treatments based on individual immune profiles.

Moreover, heightened government initiatives, including funding for research and development and the establishment of favorable regulatory frameworks, further fortifies the market. The global upsurge in chronic and infectious diseases, combined with an aging population, intensifies the need for advanced diagnostic solutions, aligning seamlessly with the capabilities of immunodiagnostics. These combined elements foreshadow a promising path for the global immunodiagnostics market, ensuring ongoing innovation, enhanced precision, and a significant transformative influence on global healthcare delivery.

Key Players Landscape and Outlook

Several prominent corporations are engaged in mergers and acquisitions in the global immunodiagnostics market. These strategic actions target resource consolidation, portfolio expansion, and acquiring innovative technologies. These efforts aid in creating extensive diagnostic solutions and fortifying market standings. Through acquisitions or mergers, firms can combine strengths, expertise, and optimize operations, improving competitiveness. The calculated approach consolidates the market and propels innovations in immunodiagnostic technologies, potentially transforming the industry landscape and enhancing healthcare outcomes more broadly. As an example, in May 2023, the privately held biotech business Freenome announced that it had purchased Oncimmune Ltd., a UK-based global immunodiagnostics developer with a commercialized CE-IVD marked EarlyCDT Lung blood test, an autoantibody platform, and a research and development pipeline of more than seven major cancer detection signatures. By adding more indicators crucial for cancer detection to its autoantibody technology, the acquisition expands Freenome's product offering.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Immunodiagnostics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Type
    • 4.2.1. Radioimmunoassay (RIA)
    • 4.2.2. ELISA
    • 4.2.3. Chemiluminescent immunoassay (CLIA)
    • 4.2.4. Fluorescent immunoassay (FIA)
    • 4.2.5. Lateral flow assay (LFA)
    • 4.2.6. Rapid Test
    • 4.2.7. Others
  • 4.3. By Product
    • 4.3.1. Reagents
    • 4.3.2. Instruments
    • 4.3.3. Software & Services
  • 4.4. By Application
    • 4.4.1. Oncology
    • 4.4.2. Endocrinology
    • 4.4.3. Infectious diseases, Allergy & Autoimmune Diseases
    • 4.4.4. Environmental Pollution
    • 4.4.5. Food Technology
    • 4.4.6. Proteomics
    • 4.4.7. Cardiac Biomarker
    • 4.4.8. Drug Monitoring
    • 4.4.9. Others
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Clinical Laboratories
    • 4.5.3. Academics & Research Centers
    • 4.5.4. Pharma & Biotech Industry
    • 4.5.5. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. South America
    • 4.6.4. Asia-Pacific
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Immunodiagnostics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Type
      • 5.1.2.1. Radioimmunoassay (RIA)
      • 5.1.2.2. ELISA
      • 5.1.2.3. Chemiluminescent immunoassay (CLIA)
      • 5.1.2.4. Fluorescent immunoassay (FIA)
      • 5.1.2.5. Lateral flow assay (LFA)
      • 5.1.2.6. Rapid Test
      • 5.1.2.7. Others
    • 5.1.3. By Product
      • 5.1.3.1. Reagents
      • 5.1.3.2. Instruments
      • 5.1.3.3. Software & Services
    • 5.1.4. By Application
      • 5.1.4.1. Oncology
      • 5.1.4.2. Endocrinology
      • 5.1.4.3. Infectious diseases, Allergy & Autoimmune Diseases
      • 5.1.4.4. Environmental Pollution
      • 5.1.4.5. Food Technology
      • 5.1.4.6. Proteomics
      • 5.1.4.7. Cardiac Biomarker
      • 5.1.4.8. Drug Monitoring
      • 5.1.4.9. Others
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Clinical Laboratories
      • 5.1.5.3. Academics & Research Centers
      • 5.1.5.4. Pharma & Biotech Industry
      • 5.1.5.5. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. Value
      • 5.1.6.1.2. Volume
      • 5.1.6.2. By Type
      • 5.1.6.2.1. Radioimmunoassay (RIA)
      • 5.1.6.2.2. ELISA
      • 5.1.6.2.3. Chemiluminescent immunoassay (CLIA)
      • 5.1.6.2.4. Fluorescent immunoassay (FIA)
      • 5.1.6.2.5. Lateral flow assay (LFA)
      • 5.1.6.2.6. Rapid Test
      • 5.1.6.2.7. Others
      • 5.1.6.3. By Product
      • 5.1.6.3.1. Reagents
      • 5.1.6.3.2. Instruments
      • 5.1.6.3.3. Software & Services
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Oncology
      • 5.1.6.4.2. Endocrinology
      • 5.1.6.4.3. Infectious diseases, Allergy & Autoimmune Diseases
      • 5.1.6.4.4. Environmental Pollution
      • 5.1.6.4.5. Food Technology
      • 5.1.6.4.6. Proteomics
      • 5.1.6.4.7. Cardiac Biomarker
      • 5.1.6.4.8. Drug Monitoring
      • 5.1.6.4.9. Others
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospitals
      • 5.1.6.5.2. Clinical Laboratories
      • 5.1.6.5.3. Academics & Research Centers
      • 5.1.6.5.4. Pharma & Biotech Industry
      • 5.1.6.5.5. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Type
  • 6.2. By Product
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Bio-Rad Laboratories, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Johnson & Johnson Services, Inc.
  • 13.3. Immunodiagnostics Systems Holdings Plc
  • 13.4. F. Hoffman-La Roche Ltd.
  • 13.5. Arkray, Inc.
  • 13.6. Siemens AG
  • 13.7. bioMerieux SA
  • 13.8. Danaher Corporation
  • 13.9. Sysmex Corporation
  • 13.10. Abbott Laboratories Inc.
  • 13.11. Diasorin S.P.A.
  • 13.12. Thermo Fisher Scientific, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 3. Global Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 5. Global Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Immunodiagnostics Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 10. North America Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 11. North America Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 12. North America Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Immunodiagnostics Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 17. United States Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 18. United States Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 19. United States Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 23. Canada Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 24. Canada Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 25. Canada Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 29. Mexico Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 30. Mexico Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 31. Mexico Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 35. Europe Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 36. Europe Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 37. Europe Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Immunodiagnostics Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 42. Germany Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 43. Germany Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 44. Germany Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 48. France Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 49. France Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 50. France Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 51. France Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 54. Italy Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 55. Italy Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 56. Italy Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 60. United Kingdom Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 61. United Kingdom Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 62. United Kingdom Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 66. Russia Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 67. Russia Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 68. Russia Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 72. Netherlands Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 73. Netherlands Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 74. Netherlands Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 78. Spain Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 79. Spain Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 80. Spain Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 84. Turkey Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 85. Turkey Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 86. Turkey Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 90. Poland Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 91. Poland Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 92. Poland Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 96. South America Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 97. South America Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 98. South America Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Immunodiagnostics Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 103. Brazil Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 104. Brazil Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 105. Brazil Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 109. Argentina Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 110. Argentina Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 111. Argentina Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 115. Asia-Pacific Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 116. Asia-Pacific Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 117. Asia-Pacific Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Immunodiagnostics Market Share (%), By Country, 2017-2031F
  • Figure 120. India Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 122. India Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 123. India Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 124. India Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 125. India Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 128. China Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 129. China Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 130. China Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 131. China Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 134. Japan Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 135. Japan Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 136. Japan Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 140. Australia Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 141. Australia Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 142. Australia Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 146. Vietnam Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 147. Vietnam Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 148. Vietnam Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 152. South Korea Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 153. South Korea Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 154. South Korea Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 158. Indonesia Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 159. Indonesia Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 160. Indonesia Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 164. Philippines Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 165. Philippines Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 166. Philippines Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 170. Middle East & Africa Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 171. Middle East & Africa Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 172. Middle East & Africa Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Immunodiagnostics Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 177. Saudi Arabia Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 178. Saudi Arabia Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 179. Saudi Arabia Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 183. UAE Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 184. UAE Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 185. UAE Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Immunodiagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Immunodiagnostics Market, By Volume, In Millions, 2017-2031F
  • Figure 189. South Africa Immunodiagnostics Market Share (%), By Type, 2017-2031F
  • Figure 190. South Africa Immunodiagnostics Market Share (%), By Product, 2017-2031F
  • Figure 191. South Africa Immunodiagnostics Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Immunodiagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023